| Financial Year |
June 30 2020 |
| Monetary Funds |
74,079,108.47 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
5,241,238.42 |
| Accounts Receivable |
101,137,408.15 |
| Advances to Suppliers |
7,327,690.30 |
| Other Receivables |
11,302,054.29 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
26,721,979.25 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
1,271,083.39 |
| Total Current Assets |
282,087,145.71 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
6,586,112.48 |
| Long-term Equity Investment |
-- |
| Investment Properties |
1,433,063.53 |
| Fixed Assetes |
371,826,558.42 |
| Under-construction Projects |
202,178,879.35 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
19,743,176.75 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
5,253,561.23 |
| Other Non-Current Assets |
14,128,206.56 |
| Sub-Total of Non-Current Assets |
621,799,558.32 |
| Total Assets |
903,886,704.03 |
| Short-Term Loans |
78,000,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
21,826,149.32 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
8,887,507.21 |
| Taxes Payable |
136,396,487.79 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
52,775,079.06 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
22,835,831.35 |
| Other Current Liabilities |
2,240,785.65 |
| Sub-Total of Current Liabilities |
340,198,653.14 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
61,105,230.26 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
655,197.48 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
63,862,050.85 |
| Total Liabilities |
404,060,703.99 |
| Paid-In Capital(Or Share Stock) |
360,090,000.00 |
| Capital Surplus |
2,537,095.85 |
| Surplus Reserve |
25,023,005.21 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
68,871,981.51 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
499,826,000.04 |
| Owner's Equity（Stockholder's Equity） |
499,826,000.04 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
903,886,704.03 |
